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A B S T R A C T
Premenstrual Dysphoric Disorder (PMDD) is characterized by cyclical mood changes resulting in clinically
significant distress and functional impairment. Studies on momentary cognitive and affective states and their
interplay during daily life over the menstrual cycle in affected women are still lacking. Using Ecological
Momentary Assessment with electronic diaries, 61 women with current PMDD and 61 healthy control women
reported their current mood, rumination, and self-acceptance eight times a day over two consecutive days per
cycle phase (menstrual, follicular, ovulatory, and late luteal phase). Results revealed that women with PMDD
showed significant increases in negative affect and rumination and decreases in positive affect and self-accep-
tance toward the end of the cycle. Lagged analyses demonstrated stronger within-person reciprocal effects of
cognitions and mood in PMDD women compared to controls with the effect of rumination on subsequent ne-
gative affect being limited to the late luteal phase. Identified stronger prospective associations between cognitive
processes and mood deteriorations in women with PMDD suggest that affected women are more sensitive to
detrimental effects of either dimension. Hence, therapeutic strategies aiming at reducing ruminative thoughts




Premenstrual Dysphoric Disorder (PMDD) is the most severe form of
premenstrual burden, causing clinically significant distress and marked
impairment of psychosocial functioning (Lanza di Scalea & Pearlstein,
2019). Outlined as a new diagnostic category in DSM-5, PMDD is de-
fined by the presence of at least five symptoms during the late luteal
phase of the menstrual cycle including at least one out of four marked
affective symptoms such as affective lability, irritability, depressed
mood or anxiety (American Psychiatric Association, 2013). A full di-
agnosis requires daily symptom ratings over two symptomatic cycles,
although a provisional diagnosis of PMDD can be made without (APA,
2013). While the less severe premenstrual syndrome has a prevalence of
about 13–20% in community samples depending on the underlying
diagnostic criteria (Beddig & Kuehner, 2017; H. U.; Wittchen, Becker,
Lieb, & Krause, 2002), PMDD afflicts 3–8% of women in fertile ages
(Dennerstein, Lehert, & Heinemann, 2012; Lanza di Scalea & Pearlstein,
2019). PMDD frequently takes a chronic course (H. U. Wittchen et al.,
2002), and suicidality is increased (Owens & Eisenlohr-Moul, 2018;
Pilver, Libby, & Hoff, 2013).
In light of the high comorbidity and symptom overlap between
PMDD with Major Depression and anxiety disorders shared vulner-
ability factors have been proposed. One such transdiagnostic factor
might be rumination, defined as the tendency to passively and repeti-
tively analyze one's distress, problems, and concerns, without taking
actions (Nolen-Hoeksema & Watkins, 2011). Previous research showed
that rumination in response to negative mood is a stable risk factor for
mental disorders, especially for depression (e.g. Huffziger, Reinhard, &
Kuehner, 2009; Lyubomirsky, Layous, Chancellor, & Nelson, 2015;
Nolen-Hoeksema, Wisco, & Lyubomirsky, 2008) but also for other
common mental disorders (Nolen-Hoeksema & Watkins, 2011). Fol-
lowing the transdiagnostic perspective, maladaptive cognitive
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processes such as rumination could also play a role in the etiology and
maintenance of PMDD. In women with PMDD, cognitive processes have
been relatively understudied and if so have been dominated by in-
vestigations of respective traits or habitual coping styles. It is thought
that those women suffering from premenstrual changes who have a
ruminative response style may be more vulnerable to developing PMDD
(cf. Craner, Sigmon, & Martinson, 2015; Craner, Sigmon, Martinson, &
McGillicuddy, 2014), pointing toward a multifactorial model in which
psychological factors interact with physiological cycle changes. In fact,
former studies found that women with premenstrual disorders tend to
use less helpful coping strategies such as rumination (Craner et al.,
2014), behavioral impulsivity (Petersen et al., 2016), non-acceptance of
emotional responses (Reuveni et al., 2016), catastrophizing (Eggert,
Witthöft, Hiller, & Kleinstäuber, 2016), or harm-avoidance (Hsu, Liu, &
Hsiao, 2007; Miller et al., 2010). There is also some evidence that trait
rumination is associated with steeper increases in premenstrual de-
pressive symptoms (Dawson et al., 2018). Furthermore, trait rumina-
tion was found to mediate the relationship between anxiety sensitivity
and premenstrual distress (Sigmon, Schartel, Hermann, Cassel, &
Thorpe, 2009). A study by Craner et al. (2015) examined momentary
maladaptive psychological processes showing that in response to ex-
perimentally induced negative affect (NA) women with premenstrual
disorders reacted with high levels of self-focused attention. Affected
women also reported higher general use of ruminative coping and self-
focused attention compared to controls. The authors propose that the
tendency of affected women to use a passive, emotion-focused, rumi-
native coping style is likely to increase emotional symptoms. Corre-
spondingly, in a recent randomized controlled trial the use of active
coping strategies was associated with symptom relief in PMDD (Weise
et al., 2019).
In contrast to studies investigating trait aspects of rumination, re-
search on moment-to-moment relationships between state cognitions
and distress during daily life in women with PMDD is lacking. To study
such phenomena, an Ecological Momentary Assessment (EMA) study
design is most appropriate. Here, multiple real-time assessments take
place during daily life, and the resulting longitudinal data series allow
the investigation of variability of momentary affect and cognitions and
their temporal relationship within individuals (cf. Trull & Ebner-
Priemer, 2013). In the context of PMDD research, EMA also enables to
study variability of such phenomena across the menstrual cycle within
persons and to compare women with and without PMDD with this re-
gard. In contrast to PMDD research, there is growing EMA-literature
examining prospective effects of momentary cognitive processes on
affect and vice versa in other populations. For example, momentary
rumination predicted subsequent levels of NA in clinical (e.g. Kircanski,
Thompson, Sorenson, Sherdell, & Gotlib, 2018; Ruscio et al., 2015) and
in community samples (e.g. Moberly & Watkins, 2008). Naturally oc-
curring NA was in turn found to be followed by increased levels of
rumination, suggesting a reciprocal relation between these two con-
structs (Moberly & Watkins, 2008). Furthermore, effects of momentary
cognitive processes on positive emotions have been documented in the
context of mindfulness (Garland, Geschwind, Peeters, & Wichers, 2015;
Jimenez, Niles, & Park, 2010; Timm et al., 2018; Welz, Reinhard,
Alpers, & Kuehner, 2018). There is evidence that dispositional mind-
fulness is associated with higher levels of positive emotions and self-
acceptance during daily life (Jimenez et al., 2010), and a recent study
by Timm et al. (2018) demonstrated that mindfulness training led to
improved positive affect (PA) and self-acceptance in remitted depressed
patients, whereas NA and rumination decreased. Following these find-
ings, rumination and NA as well as self-acceptance and PA appear to be
tightly linked in daily life. While ruminative thinking and negative
mood seem to be driven by a downward spiral especially in clinical
samples (e.g. Kircanski et al., 2018; Nolen-Hoeksema et al., 2008), an
upward spiral has been proposed for positive thinking and PA (Garland
et al., 2015).
Given the strong affective component in PMDD, the possible role of
cognitive processes in influencing affective processes is of particular
interest. Since symptoms occur in a cyclical recurring pattern, it is likely
that women with PMDD are especially vulnerable to dysfunctional
cognitions during the late luteal phase of the menstrual cycle (cf. Read,
Perz, & Ussher, 2014). Hence, similar to studies with other clinical
samples (e.g. Kircanski et al., 2018), a downward spiral of increased
rumination and decreased self-acceptance exerting mood worsening
and vice versa might be effective in PMDD women particularly in the
late luteal phase. Using EMA in PMDD research has been repeatedly
called for (see Bosman, Jung, Miloserdov, Schoevers, & aan het Rot,
2016; Owens & Eisenlohr-Moul, 2018), and we have implemented a
first EMA study in this context (Beddig, Reinhard, & Kuehner, 2019).
Here, we could already demonstrate that women with PMDD showed
heightened subjective stress reactivity towards daily life stressors par-
ticularly during the late luteal phase and a blunted activity of the hy-
pothalamic-pituitary-adrenal axis (HPAA) across the menstrual cycle.
1.2. Study aims
Aims of the present paper were as follows. We first sought to ex-
amine possible menstrual cycle-related variations in affective and
cognitive states in the PMDD sample by Beddig et al. (2019). It was
expected that in PMDD women negative mood and rumination would
be highest whereas positive mood and self-acceptance would be lowest
during the late luteal phase compared to other cycle phases, while no
such cycle-related effects were expected for controls. The second aim
was to investigate possible reciprocal time-lagged relationships be-
tween rumination and NA as well as between self-acceptance and PA by
also checking for possible cycle-dependent effects. Specifically, it was
hypothesized that prospective effects of cognitive on affective states
and vice versa would be stronger in PMDD women compared to con-
trols, particularly in the late luteal phase.
2. Method
2.1. Participants
Women were recruited via local family doctors and gynecologists,
flyers, social networks, and the homepage of the Central Institute of
Mental Health (CIMH, for detailed information see also Beddig et al.,
2019). To take part in the study, women had to fulfill the following
inclusion criteria: a) age between 20 and 42, b) consistent length of
menstrual cycle between 22 and 34 days, c) fulfillment of diagnostic
criteria of a PMDD diagnosis based on DSM-5 criteria (PMDD group) or
exempt from any PMDD affective core symptoms (control group). Ex-
clusion criteria were being pregnant or lactating during the last six
months, a history of gynecological diseases, use of hormonal contra-
ceptives and pharmaceutical medication, late evening or night shifts,
body mass index< 18 or>35, a lifetime history of psychotic or bi-
polar disorder, and current alcohol or substance abuse or dependence.
Controls were matched regarding age and education. Initially 140
women were enrolled, of whom 18 (12.9%, nine per group) withdrew
from the study during the EMA phase. Reasons for discontinuating in-
cluded inconsistencies with menstrual cycle reports (n = 14), severe
technical problems (n = 2), decision to start hormonal contraceptives
(n = 1), and positive pregnancy test (n = 1). Hence, the final sample
consisted of 61 women diagnosed with PMDD and 61 controls. The
study protocol was approved by the ethics committee of the Medical
Faculty Mannheim, Heidelberg University. All participants gave written
informed consent and were paid 100€ for completing the study.
2.2. Ecological Momentary Assessment (EMA) procedure
EMA was carried out using Motorola Moto G 2nd Generation
smartphones with the software movisensXS, version 0.6.3658 (movi-
sens GmbH, Karlsruhe, Germany). EMA took place during four cycle
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phases of a menstrual cycle with two consecutive EMA-days per cycle
phase. Individual calendars were prepared for each woman based on
the date of her last menstruation onset and the average length of her
menstruation and of her menstrual cycle. Assessments during the
menstrual phase took place on the second and third day of menstruation
(M = 2.95 days, SD = 2.21). The follicular phase was examined on the
second and third day after the end of menstruation (M = 8.61 days,
SD = 1.94). The ovulatory phase (M = 17.15 days, SD = 2.0) was
determined by a chromatographic ovulation test (gabControl hlH
Ovulationsteststreifen, gabmed, Cologne) indicating a rise in luteinizing
hormone levels in urine. Participants were asked to start testing a few
days before the predicted ovulation until the result was positive, and
then to complete the diary on the next two days. If ovulation did not
occur, participants were asked to repeat the test in the following
menstrual cycle. Assessments of the late luteal phase took place on the
fourth and third day before the next menstruation was expected
(M = 26.38 days, SD = 3.02). Phases were validated according to the
ovulation test and the exact time of the onset of the next menses. To
avoid sequence effects, participants started EMA in different cycle
phases.
There were eight assessments per day, with the first assessment
taking place at 9.00 a.m. and the remaining seven assessments taking
place between 10:00 a.m. and 09:30 p.m. at random time points at
averaged 103 min apart (SD = 25.0) with a minimum interval of
45 min. Each assessment was announced by an acoustic signal and took
3–4 min to complete. Participants had 5 min to respond, and assess-
ments could be delayed by 15 min. If participants were unable to re-
spond or rejected the alarm, the assessment was saved as missing. After
having completed the EMA days participants returned the device and
were compensated for their participation.
2.3. Structured assessment of psychopathology
The diagnosis of PMDD was verified using the Structured Interview
for DSM-IV TR PMDD (SCID-PMDD; Accortt, Bismark, Schneider, &
Allen, 2011) during the diagnostic baseline session. The SCID-PMDD
includes all symptom criteria together with the required impairment
criterion and the exclusion criterion of a mere exacerbation of symp-
toms of another disorder. The interview format is modeled after SCID-I
(see below) and has shown high interrater reliability (κ = 0.96)
(Accortt et al., 2011). For the PMDD group, the criteria for PMDD ac-
cording to the SCID-PMDD had to be met with the diagnostic algorithm
adapted for DSM-5. To avoid further participant burden, prospective
daily ratings during at least two symptomatic cycles before study in-
clusion were not required. Control women had to be free of any PMDD
affective core symptoms. Premenstrual physical symptoms were not an
exclusion criterion for controls, given the fact that the majority of
naturally cycling women are experiencing physical symptoms of
varying degree during the late luteal and menstrual phase (Tschudin,
Bertea, & Zemp, 2010).
Other mental health comorbidities and exclusion criteria were as-
sessed with the SCID-I Interview (H. Wittchen, Wunderlich, Gruschwitz,
& Zaudig, 1997), a psychometrically sound semi-structured interview
for mental disorders. Furthermore, demographics were assessed during
the baseline session together with the severity of depressive symptoms,
measured with the 21-item Beck Depression Inventory (BDI-II; Beck,
Steer, & Brown, 1996) and trait anxiety measured with the 20-item
Spielberger Trait Anxiety Inventory (STAI-T; Spielberger, Gorsuch, &
Lushene, 1970). Interviews were conducted by a trained research psy-
chologist.
2.4. Ecological Momentary Assessment (EMA) variables
NA and PA. At each assessment, participants responded on a 7-point
Likert scale to negative and positive mood adjectives. For NA, partici-
pants were asked to rate how upset, irritated, nervous, listless, down
and bored they felt and for PA how cheerful, energetic, enthusiastic,
satisfied, relaxed and calm they felt. These items were derived from the
Positive and Negative Affect Schedule (PANAS; Watson, Clark, &
Tellegen, 1988) and have been used in previous EMA-studies (Kuehner,
Welz, Reinhard, & Alpers, 2017; Timm et al., 2018; Welz et al., 2018).
Rumination. Rumination was assessed on a 7-point Likert scale with
the item “At the moment I am stuck on negative thoughts and cannot
disengage from them”, capturing the uncontrollability facet of rumi-
nation (cf. Kuehner et al., 2017; Raes, Hermans, Williams, Bijttebier, &
Eelen, 2008; Timm et al., 2018).
Self-acceptance. Self-acceptance was assessed with the item “At the
moment I accept myself how I am” on a Likert scale 1–7 (cf. Timm et al.,
2018).
Daily stress events. To assess daily stress events subjects reported on a
7-point bipolar scale (−3 = very unpleasant, 0 = neutral, and
3 = very pleasant) the most important event between the current and
the previous beep (cf. Wichers et al., 2009).
2.5. Data analysis
Statistical analyses were performed using multilevel models, taking
into account that the present data were organized within nested levels.
Analyses showed that for all dependent variables the three-level model
including the day-level had a better fit than the two-level model ac-
cording to fit indices (AIC and BIC) (Hox, Moerbeek, & Van de Schoot,
2017). Therefore, for each outcome a multilevel model assuming three
levels was applied with single assessments (level 1) nested within days
(level 2), nested within persons (level 3). All models included random
intercepts at level two and three, allowing individual baseline levels of
the dependent variables to differ between persons and days. All statis-
tical models included group status (PMDD/controls), cycle phase
(menstrual, follicular, ovulatory, and late luteal) as a categorical vari-
able, and the interaction group*menstrual cycle phase. Further we
controlled for day (sampling days 1–8) to account for assessment re-
activity and for time of the day to account for time-dependent variation
within days in respective outcomes. For each outcome we checked
whether time2 was significant, and if so retained it in the models. The
quadratic time effect was only significant for NA which was highest in
the mid-afternoon.
To examine prospective effects of daily life variables, lagged values
were constructed for all observations, except for those representing the
first response of a day. In the respective models, all main effects as well
as the 2- and 3-way interactions between predictors of interest were
included. The models tested the effect of the lagged predictor variable
(e.g. rumination) at time t on the respective outcome variable (e.g. NA)
at time t + 1, while controlling for the lagged outcome at time t to
account for any carryover, and for the lagged predictor aggregated at
the person level at time t to adjust for time invariant between-subject
effects (B–S). To facilitate interpretation, predictor variables were
person-mean centered prior to the analyses. This produced within-
subject (W–S) predictors that vary within, but not between individuals.
Importantly, these predictors, originally measured on a continuous
scale, were entered as dichotomized variables via person mean split due
to the application of complex multilevel models. Dichotomization re-
sulted in binary variables. Here, the focus of analysis was to compare
worse states than usual with usual or better states (e.g. NA (W–S) > 0
describes NA above the intraindividual average level compared to NA
(W–S) ≤ 0, which describes NA equal or below average level). In doing
so we were able to estimate and test conditional interactions (in case of
significant 3-way interactions) and to evaluate simple effects (in case of
significant 2-way interactions), which is essential especially if checking
for cycle-dependent changes (i.e., 3-way interactions group*cycle
phase*predictor, in which interactions of each pair of variables are
allowed to vary with the level of the third variable).
As an example of such a multilevel model (here: lagged rumination
predicting negative affect (NA)), the level 1 model can be described as:
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Y (negative affect) ijk = π0jk + π1jk(cp_nr) * cycle phase(cp_nr)ijk + π2jk
* lagged negative affectijk
+ π3jk * time of dayijk + π4jk * (time of day)2ijk + π5jk * lagged rumi-
nation (dich)ijk
+ π6jk(cp_nr) * cycle phase(cp_nr)ijk X lagged rumination (di-
ch)ijk + εijk
Here, Yijk represents the level of negative affect at time i at assess-
ment day j for person k. The π coefficients represent the intercept and
the fixed main and interaction effects at level 1, the εijk denote the
residuals at level 1. The level 2 model can be described as:
π0jk = β00k + β01k * assessment dayjk + u0jk (and π1jk = β10k;
π2jk = β20k; π3jk = β30k; π2jk = β20k; …; π6jk = β60k) with the u0jk
representing random intercepts for the assessment day j within person
k. The level 3 model can be described as:
β00k = γ000 + γ001 * groupk + γ002 * lagged rumination (B–S)k + v00k;
β01k = γ010; β10k = γ100 + γ110 * groupk; β20k = γ200; β30k = γ300;
β40k = γ400;
β50k = γ500 + γ510 * groupk; β60k = γ600 + γ610 * groupk
Here the v00k indicate the random intercept for person k. Note that
we included three dummy variables for the categorical variable cycle
phase, and the appendix “(cp_nr)” indicates a specific cycle phase.
To control for possible confounding effects of depressive symptom
severity, trait anxiety symptoms and daily stress events, analyses were
repeated by controlling for these variables.
Our hypotheses-driven main analyses investigating 3-way interac-
tions (cycle phase*lagged predictor*group) were not Bonferroni-ad-
justed. In case of a nonsignificant interaction effect with cycle phase,
we looked at possible significant 2-way interactions (group*lagged
predictor) in the model, the latter indicating phase-independent group
differences in the association between lagged predictor and outcome.
Since these analyses were exploratory, respective p-values were
Bonferroni-corrected for multiple testing, as suggested by Hox et al.
(2017). Similarly, all post hoc tests were Bonferroni-adjusted. All sta-
tistical analyses were performed using the statistical software IBM SPSS
Version 23. The significance level was set at α = 0.05.
3. Results
3.1. Compliance
Statistical analyses were based on 122 participants (PMDD group:
N = 61; control group: N = 61). Altogether, 6818 of 7808 possible
assessments were recorded, which corresponds to an overall response
rate across participants of 87.3%, reflecting a high level of compliance
(cf. Courvoisier, Eid, & Lischetzke, 2012).
3.2. Descriptives
Descriptive information on demographic, clinical, and EMA vari-
ables are listed in Table 1. Groups did not significantly differ with re-
spect to age, education, marital status, work situation, percentage with
children, and mean duration of the menstrual cycle. In contrast, PMDD
women displayed higher BDI-II mean scores, higher trait anxiety levels,
and a larger percentage had a lifetime diagnosis of depression.
3.3. Cycle dependent variation of affect and cognitions
To investigate whether women with and without PMDD differed in
cognitive and affective states over the menstrual cycle, four separate
models were calculated. As shown in Table 2, the group*cycle phase
interaction was significant in predicting NA (p < 0.001), PA
(p < 0.001), rumination (p < 0.001), and self-acceptance
(p < 0.001). Post hoc tests using Bonferroni correction revealed higher
levels of NA and rumination as well as lower levels of PA during the late
luteal phase in women with PMDD compared to all other cycle phases
(p's ≤ 0.01) and decreased levels of self-acceptance compared to the
follicular and ovulatory phase (pmenstrual = 0.164, pfollicular < 0.001,
povulatory < 0.001). In contrast, no cycle phase effect on momentary
states was observed in control women (all p's > 0.55). For graphical
demonstration, see Fig. 1.
3.4. Time-lagged models of predictors and outcomes
3.4.1. Time-lagged models of NA and rumination
The analysis investigating lagged rumination predicting NA re-
vealed significant time-lagged associations varying across menstrual
cycle phases and groups (group* cycle phase* rumination lag (F(3,
4935) = 2.87, p= 0.035, see Table 3). Post hoc tests using Bonferroni
correction revealed that in PMDD women, momentary levels of rumi-
nation (at time t) above their individual average significantly predicted
a premenstrual increase in NA at the subsequent time point (t+1)
(p < 0.01), whereas for controls no menstrual cycle-related effect was
observed (all p's > 0.37) (see Fig. 2 A).
The analysis investigating lagged NA predicting rumination re-
vealed no significant three-way interaction group* cycle phase* NA lag
(F(3, 5270) = 0.24, p = 0.868). However, we identified a significant
group* NA lag effect (F(1, 5242) = 7.42, p = 0.018 (Bonferroni-cor-
rected), see Table 3). Fig. 2 B indicates that in PMDD women mo-
mentary NA levels (at time t) above average resulted in a stronger in-
crease in momentary rumination at the subsequent time point (t+1)
compared to controls regardless of cycle phase. Post hoc tests revealed
that for both groups the prospective effect of NA on rumination was
significant (PMDD: p < 0.001, controls: p < 0.001).
3.4.2. Time-lagged models of PA and self-acceptance
The analysis investigating lagged self-acceptance predicting PA re-
vealed no significant effect of group*cycle phase*self-acceptance lag (F
(3, 2779) = 0.49, p = 0.689). We identified a significant interaction
group*self-acceptance lag (F(1, 44400) = 7.86, p= 0.015 (Bonferroni-
corrected), see Table 4). Fig. 2 C indicates that in PMDD women mo-
mentary levels of self-acceptance below average (at time t) resulted in a
stronger decrease in PA at the subsequent time point (t+1) compared
to controls regardless of cycle phase. Post hoc tests revealed that the
prospective effect of self-acceptance on PA was only significant in
women with PMDD (p < 0.001), not in controls (p = 0.936).
While the analysis investigating lagged PA predicting self-accep-
tance revealed no significant three-way interaction group*cycle phase*
PA lag (F(3, 5212) = 0.90, p = 0.438), the interaction group* PA lag
demonstrated a significant effect on self-acceptance (F(1,
5201) = 16.70, p < 0.001 (Bonferroni-corrected), see Table 4). Fig. 2
D indicates that in PMDD women momentary levels of PA below
average (at time t) resulted in a stronger decrease in self-acceptance to
the subsequent time point (t+1) compared to controls regardless of
cycle phase. Post hoc tests revealed that the prospective effect of PA on
self-acceptance was only significant in women with PMDD
(p < 0.001), not in controls (p = 0.147).
3.4.3. Confounder analysis
Including the severity of depressive symptoms (BDI-II), anxiety
symptoms (STAI-T) and daily stress events as covariates did not change
any of the reported effects. Therefore, the present results were not af-
fected by possible group differences in depressive and anxiety symptom
severity and daily stress events.
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4. Discussion
4.1. Summary of results
The purpose of the current EMA study was to explore menstrual
cycle-related variations of affective and cognitive states during daily
life and to examine time-lagged associations between these states in
women with PMDD and healthy controls. While affective symptoms of
low mood, decreased interest, irritability, and anxiety occur as part of
many mental disorders, the prominent feature that distinguishes PMDD
from similar entities is its time course, with the late luteal phase con-
finement of symptoms (APA, 2013). In this regard, our EMA data -
prospectively collected over the menstrual cycle and analyzed with
multilevel models – show that women with PMDD exhibited the highest
NA and the lowest PA in the late luteal phase, thereby clearly con-
firming a symptomatic state of mood deterioration during this phase in
a naturalistic, real-time context in the present PMDD sample. Moreover,
PMDD women also reported highest levels of rumination and lowest
levels of self-acceptance during the late luteal phase. In contrast,
healthy women did not show any cycle-dependent variation of mood
and cognitions.
Lagged models revealed that especially in the late luteal phase
PMDD women reacted to high levels of rumination with increased le-
vels of NA. Therefore, intensive rumination seems to have a particular
mood-impairing effect toward the end of the cycle in these women.
Previous studies have indicated that habitual rumination is associated
with experiencing premenstrual distress (Craner et al., 2014; Dawson
et al., 2018). By focusing on momentary within-person associations this
study adds significantly to existing research by showing that particu-
larly in the late luteal phase intraindividual high levels of rumination
predicted deterioration in NA in women with PMDD. Our results further
indicate that in PMDD women increased NA levels predicted a stronger
subsequent increase in rumination compared to controls regardless of
cycle phase. This adds to previous research examining habitual coping
styles in the context of premenstrual disorders (e.g. Craner et al., 2015,
2014; Petersen et al., 2016; Reuveni et al., 2016). By focusing on state
cognitions the present study shows that women with PMDD tend to
ruminate in response to negative affective states more strongly than
nonaffected women across the menstrual cycle, thereby pointing to-
ward a trait-like characteristic of ruminative responses to negative af-
fect in PMDD.
Taking both lagged paths together our findings suggest a reciprocal
relationship between rumination and NA especially in the late luteal
phase. Following the transdiagnostic perspective of rumination as a
dysfunctional key mechanism in mental disorders (e.g. Lyubomirsky
et al., 2015; Nolen-Hoeksema et al., 2008; Nolen-Hoeksema & Watkins,
2011) our findings align with this concept by demonstrating a char-
acteristic cycle-dependency in the context of PMDD.
Moreover, momentary levels of low self-acceptance resulted in a
stronger decrease in PA and vice versa in PMDD women compared to
controls. These observations further indicate a stronger sensitivity of
affected women for the effects of negative or lack of positive self-re-
ferential thoughts. Again, we did not identify cycle-dependency for
these associations, thereby pointing toward a more general underlying
vulnerability of negative self-referential thoughts that could make
women also more likely to developing PMDD. Importantly, controlling
for daily stress events, depressive symptom severity as well as for trait
anxiety levels did not affect the study results. Therefore, although co-
morbidity with lifetime depression was high, our study suggests that
PMDD characteristics uniquely contributed to the present findings.
Table 1
Descriptions of women with PMDD and controls.
PMDD (n = 61) %/M (SD) Controls (n = 61) %/M (SD) Test statistic p
Demographic Variables
Age 29.4 (5.8) 29.5 (5.1) t = −0.03 .977
Education (% with high school degree 72.1% 75.4% Chi2 = 0.17 .681
Work Situation (% in regular job or education) 80.3% 90.2% Chi2 = 2.35 .126
Marital Status (% married or living together) 60.7% 59.0% Chi2 = 0.03 .853
Children (%) 24.6% 26.2% Chi2 = 0.04 .835
BMI 23.6 (4.1) 23.5(4.3) t = 0.12 .903
Clinical Variables
Lifetime Diagnosis of Depression (SCID-I) 54.1% 21.3% Chi2 = 13.96 < .001
BDI-IIa score at baseline 10.9 (8.9) 4.8 (5.6) t = 4.53 < .001
STAI-Tb score at baseline 45.6 (11.3) 37.2 (8.6) t = 4.61 < .001
EMAc Variables
Compliance Rate 86.6% 88.0% Chi2 = 33.62 .071
Duration (in days) of Menstrual Cycle during EMA 29.0 (3.1) 29.4 (3.7) t = −0.77 .444
Duration (in days) of Period during EMA 5.3 (1.1) 5.6 (1.7) t = −0.85 .399
a BDI-II=Beck Depression Inventory-Revised.
b STAI-T = Spielberger Trait Anxiety Inventory.
c EMA = Ecological Momentary Assessment.
Table 2
Fixed effects of menstrual cycle phase and group on negative affect, positive affect, rumination, and self-acceptance.
Outcome Menstrual Cycle Phase Group * Cycle Phase





























2.2 ± 1.5 1.9 ± 1.3 2.8 ± 1.7
1.9 ± 1.3







5.1 ± 1.4 5.5 ± 1.4 4.5 ± 1.5
5.5 ± 1.4
(3,840) 18.92 < .001
Note. Models included random intercepts at level 2 and 3 as well as fixed effects for time, time2 (if significant), day, group, and cycle phase.
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In conclusion, our study points to the relevance of assessing affec-
tive and cognitive processes by EMA in real world settings to be able to
demonstrate heightened vulnerability in women with PMDD towards
worsening of their mood and towards increased negative and decreased
positive self-referential thinking during the late luteal phase of their
menstrual cycle. Furthermore, EMA enabled us to identify phase-spe-
cific and phase-unspecific reciprocal associations between dysfunc-
tional momentary affective and cognitive states in respective within-
person associations in these women. In general, our findings also
strengthen previous research highlighting the role of psychological
factors in premenstrual disorders (e.g. Craner, Sigmon, & Young, 2016;
Kleinstauber et al., 2016; Reuveni et al., 2016; Weise et al., 2019).
4.2. Future perspectives and clinical implications
This is likely the first EMA study assessing menstrual cycle-related
variations of cognitive and affective daily life processes and their in-
terplay in women with PMDD. In this context, EMA can clearly improve
PMDD research due to higher ecological validity of assessed phe-
nomena compared to retrospectively assessed clinical symptoms. EMA
also typically covers more basic affective and cognitive features and
may therefore provide greater sensitivity for connecting psychological
with biological processes (cf. Conner & Barrett, 2012; Huffziger et al.,
2013). Furthermore, EMA appears to be optimally suited to capture
between-as well as within-person variability in momentary states and
their interplay across the menstrual cycle, which is particularly im-
portant for studying premenstrual disorders (cf. Bosman et al., 2016;
Owens & Eisenlohr-Moul, 2018).
Study findings might be relevant for therapeutic perspectives in
PMDD. Results revealed that women with PMDD seem to be more prone
of using rumination as a trait-like emotion regulation strategy to deal
with negative affect states across cycle phases, whereas high in-
traindividual rumination levels seem to trigger affect deterioration
particularly in the late luteal phase. Hence, rumination, identified as
transdiagnostic risk factor for a series of mental disorders (cf. Nolen-
Hoeksema & Watkins, 2011) may also be a potential therapeutic target
for reducing the burden of PMDD. In this context mindfulness based
interventions appear to be promising (cf. Petersen et al., 2016). For
example a non-clinical study by Lustyk, Gerrish, Douglas, Bowen, and
Marlatt (2011) found that high dispositional mindfulness was linked to
less premenstrual symptoms, and studies with other clinical samples
(e.g. Garland et al., 2015; Timm et al., 2018) showed that mindfulness
training reduced negative and enhanced positive daily life cognitions
such as momentary rumination and self-acceptance, and improved af-
fect. However, methodological sound randomized controlled trials ex-
amining mindful interventions in women with PMDD are still lacking,
which might be an important purpose for future research. In parallel, a
first randomized controlled trial examining internet-based cognitive-
behavioral therapy for PMDD by Weise et al. (2019) demonstrated that
active coping when dealing with premenstrual symptoms predicted
better treatment outcome, thereby underlining the importance to ad-
dress coping styles. Clearly, further research is warranted to assess
Fig. 1. Estimated mean scores of daily life variables
(NA: negative affect; PA: positive affect; RUM: ru-
mination; SA: self-acceptance) over the menstrual
cycle for women with PMDD and controls. Note.
Error bars represent standard error of the mean.
Models include random intercepts at level 2 and 3 as
well as fixed effects for time, time2 (if significant),
assessment day, group, and cycle phase.
Table 3
Time-lagged models of negative affect and rumination.
3-way Interaction Model
df F p
Outcome Negative Affect t+1
Fixed effects
Intercept (1,160) 90.33 < .001
Groupa (1,121) 13.75 < .001
Cycle phaseb (3,585) 16.05 < .001
Negative Affect (W–S) (t) (1,4814) 355.84 < .001
Rumination (B–S) (1,119) 167.01 < .001
Rumination (W–S) (t)c (1,5257) .25 .618
Group * Cycle phase (3,588) 16.86 < .001
Rumination * Group (1,5306) .11 .746
Rumination * Cycle phase (3,4942) .55 .648
Rumination *




Intercept (1,128) 3.81 .053
Groupa (1,118) .24 .624
Cycle phaseb (3,5215) 9.82 < .001
Rumination (W–S) (t)c (1,5207) 168.78 < .001
Negative Affect (B–S) (1,117) 168.19 < .001
Negative Affect (W–S) (t)d (1,5244) 56.77 < .001
Group * Cycle phase (3,5216) 12.68 < .001
Negative Affect * Group (1,5242) 7.42 .006e
Negative Affect * Cycle phase (3,5271) 1.43 .233
Negative Affect * Group * Cycle phase (3,5270) .24 .868
Note. W–S: within-subject (person mean-centered). B–S: between-subject.
Models include random intercepts at level 2 and 3 as well as fixed effects for
time, timeb (if significant), and assessment day. Time t+1 denotes the following
prompt.
a Reference category: Controls.
b Reference category: Late luteal phase.
c Reference category: Rumination (W–S) t > 0.
d Reference category: Negative affect (W–S) t > 0.
e Before Bonferroni correction.
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which interventions are effective in women with PMDD. Moreover,
longitudinal research would aid in identifying predictive effects of
momentary cognitive and affective processes and their interplay for the
clinical course of PMDD, which could, in turn, provide targeting aims
for therapy.
4.3. Strengths and limitations
Strengths of the current study include the investigation of a rela-
tively large PMDD sample together with a control sample strictly
matched regarding age and education level, the intensive longitudinal
EMA-design covering all four cycle phases, the validation of the ovu-
lation phase by a chromatographic ovulation test and the focus on
temporal within-person processes to understand the momentary re-
lationships between cognitive and affective states.
The study also has some limitations. First, given the exclusion of
antidepressant and hormonal treatments, which are currently the most
frequent treatments for PMDD (Epperson et al., 2012; Marjoribanks,
Brown, O'Brien, & Wyatt, 2013) the results might not be representative
of all women with PMDD. Second, even though overall compliance was
high and comparable between groups, nine women per group (12.9%)
dropped out due to different reasons. This could have led to a sample of
more highly motivated women. Third, we did not apply the criterion of
confirmation of daily symptom ratings during two consecutive symp-
tomatic cycles prior to study inclusion. The reason for this was to re-
duce participant burden in this type of intensive repeated random
measurement design. Thus, the diagnosis of PMDD must be considered
provisional. However, prevalence rates of moderate to severe pre-
menstrual symptoms derived from retrospective epidemiological stu-
dies have been found to be consistent with those using prospective
ratings (Cunningham, Yonkers, O'Brien, & Eriksson, 2009). Fourth,
model complexity of multilevel models resulted in dichotomizing the
main time-lagged variables of interest, which may have led to reduced
explanatory variance. Fifth, to further increase the accuracy of
Fig. 2. Estimated mean values of the time-lagged
outcomes negative affect (NA, with predictor rumi-
nation (RUM), Fig. 2 A) and RUM (with predictor
NA, Fig. 2 B) as well as time-lagged outcomes posi-
tive affect (PA, with predictor self-acceptance (SA),
Fig. 2 C) and SA (with predictor PA, Fig. 2 D) for
women with PMDD and controls. Note. Error bars
represent standard error of the mean. W–S: within-
subject (person mean-centered). Models include
time, time2 (if significant), assessment day, group,
cycle phase, lagged outcome and lagged predictor
aggregated at the person level as covariates.
Table 4
Time-lagged models of positive affect and self-acceptance.
3-way Interaction Model
df F p
Outcome Positive Affect t+1
Fixed effects
Intercept (1,128) 124.89 < .001
Groupa (1,120) 8.07 .005
Cycle phaseb (3,486) 13.73 < .001
Positive Affect (W–S) (t) (1,4758) 372.84 < .001
Self-acceptance (B–S) (1,120) 125.69 < .001
Self-acceptance (W–S) (t)c (1,4886) 5.80 .016
Group * Cycle phase (3,487) 8.61 < .001
Self-acceptance * Group (1,4440) 7.86 .005a
Self-acceptance * Cycle phase (3,2797) 2.39 .067
Self-acceptance * Group * Cycle phase (3,2779) .49 .689
Outcome Self-acceptance t+1
Fixed effects
Intercept (1,120) .20 .656
Groupa (1,119) .02 .894
Cycle phaseb (3,5199) 7.23 < .001
Self-acceptance (W–S) (t)c (1,5197) 789.63 < .001
Positive Affect (B–S) (1,119) 133.12 < .001
Positive Affect (W–S) (t)d (1,5200) 31.79 < .001
Group * Cycle phase (3,5199) 11.05 < .001
Positive Affect * Group (1,5201) 16.70 < .001e
Positive Affect * Cycle phase (3,5212) 2.35 .071
Positive Affect * Group * Cycle phase (3,5212) .90 .438
Note. W–S: within-subject (person mean-centered). B–S: between-subject.
Models include random intercepts at level 2 and 3 as well as fixed effects for
time, and assessment day. Time t+1 denotes the following prompt.
a Reference category: Controls.
b Reference category: Late luteal phase.
c Reference category: Self acceptance (W–S) t ≥ 0.
d Reference category: Positive affect (W–S) t ≥ 0.
e Before Bonferroni correction.
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conclusions, it would be beneficial to apply the EMA protocol over two
or more consecutive menstrual cycles, which was not possible in the
present study due to limited resources and may also provoke participant
burden. Sixth, the EMA items were administered in a fixed order, thus a
potential inflation of their associations cannot be excluded. Seventh,
our study design does not allow to determine causal pathways between
PMDD and daily life experiences. So it is unclear whether strong time-
lagged associations between cognitive and affective daily life variables
represent a vulnerability factor for developing PMDD or are rather the
consequence of the disorder. Here, clearly more longitudinal research is
warranted. A further limitation refers to the assessment of only two
days per cycle phase. Although a regular cycle was a premise to take
part in the study, we sometimes might have missed days with the
highest impairment. Finally, we did not assess the content of ruminative
thoughts. Ruminating about symptoms might be especially crucial for
affect deteriorations in women with PMDD (cf. Craner et al., 2014).
Further research might address these aspects as well.
4.4. Conclusions
This EMA-study examined cycle-related variations of momentary
cognitive and affective characteristics and their time-lagged associa-
tions in women with PMDD. Findings suggest stronger associations
between cognitive (rumination and self-acceptance) and mood vari-
ables (NA and PA) in affected women compared to controls. These
findings highlight the role of cognitive processes in everyday settings
and may have important implications for interventions aimed at pre-
venting and treating PMDD.
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